Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα Full Text
The Journal of Clinical Investigation, 08/01/2012
Radomska HS et al. – This data strongly suggest that targeting the CDK1 pathway might be applied in the treatment of FLT3ITD mutant leukemias, especially those resistant to FLT3 inhibitor therapies



